NCT06107036View on ClinicalTrials.gov

A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

July 25, 2024

Study Completion Date

July 25, 2024

Conditions
Healthy
Interventions
DRUG

BI 1015550

BI 1015550

DRUG

Moxifloxacin

Moxifloxacin

DRUG

Placebo

Placebo-matching BI 101550

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06107036 - A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities | Biotech Hunter | Biotech Hunter